These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 28948961)

  • 1. Pefloxacin as a surrogate marker for quinolone susceptibility in
    Sharma P; Dahiya S; Kumari B; Balaji V; Sood S; Das BK; Kapil A
    Indian J Med Res; 2017 May; 145(5):687-692. PubMed ID: 28948961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Pefloxacin Disk Diffusion Method for Detection of Fluoroquinolone-Resistant Salmonella enterica.
    Skov R; Matuschek E; Sjölund-Karlsson M; Åhman J; Petersen A; Stegger M; Torpdahl M; Kahlmeter G
    J Clin Microbiol; 2015 Nov; 53(11):3411-7. PubMed ID: 26292292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of pefloxacin as a surrogate marker to detect ciprofloxacin susceptibility in Salmonella enterica serotypes Typhi and Paratyphi A.
    Moin S; Zeeshan M; Laiq S; Raheem A; Zafar A
    J Pak Med Assoc; 2020 Jan; 70(1):96-99. PubMed ID: 31954032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility pattern and sequence analysis of DNA gyrase and DNA topoisomerase IV in Salmonella enterica serovars Typhi and Paratyphi A isolates with decreased susceptibility to ciprofloxacin.
    Misra R; Thakare R; Amrin N; Prasad KN; Chopra S; Dhole TN
    Trans R Soc Trop Med Hyg; 2016 Aug; 110(8):472-9. PubMed ID: 27618918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of ciprofloxacin-resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India.
    Gaind R; Paglietti B; Murgia M; Dawar R; Uzzau S; Cappuccinelli P; Deb M; Aggarwal P; Rubino S
    J Antimicrob Chemother; 2006 Dec; 58(6):1139-44. PubMed ID: 17071955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade.
    Sharma P; Dahiya S; Manral N; Kumari B; Kumar S; Pandey S; Sood S; Das BK; Kapil A
    Indian J Med Microbiol; 2018; 36(1):70-76. PubMed ID: 29735830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoroquinolone susceptibility testing of Salmonella enterica: detection of acquired resistance and selection of zone diameter breakpoints for levofloxacin and ofloxacin.
    Sjölund-Karlsson M; Howie RL; Crump JA; Whichard JM
    J Clin Microbiol; 2014 Mar; 52(3):877-84. PubMed ID: 24391204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of Pefloxacin for detection of fluoroquinolone (FQ) resistance among
    Inayath SB; Broor S; Gupta R; Agarwal P; Majumder S; Anveshi AK; Gaind R
    J Med Microbiol; 2021 Aug; 70(8):. PubMed ID: 34356003
    [No Abstract]   [Full Text] [Related]  

  • 9. Suboptimal clinical response to ciprofloxacin in patients with enteric fever due to Salmonella spp. with reduced fluoroquinolone susceptibility: a case series.
    Slinger R; Desjardins M; McCarthy AE; Ramotar K; Jessamine P; Guibord C; Toye B
    BMC Infect Dis; 2004 Sep; 4():36. PubMed ID: 15380025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone resistance in Salmonella typhi and S. paratyphi A in Bangalore, India.
    Joshi S; Amarnath SK
    Trans R Soc Trop Med Hyg; 2007 Mar; 101(3):308-10. PubMed ID: 16950486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced susceptibility to ciprofloxacin and gyra gene mutation in North Indian strains of Salmonella enterica serotype Typhi and serotype Paratyphi A.
    Renuka K; Kapil A; Kabra SK; Wig N; Das BK; Prasad VV; Chaudhry R; Seth P
    Microb Drug Resist; 2004; 10(2):146-53. PubMed ID: 15256030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Surrogate Disk Tests for Detection of Ciprofloxacin and Levofloxacin Resistance in Clinical Isolates of Salmonella enterica.
    Deak E; Skov R; Hindler JA; Humphries RM
    J Clin Microbiol; 2015 Nov; 53(11):3405-10. PubMed ID: 26292293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug-resistant and extended-spectrum beta-lactamase (ESBL)-producing Salmonella enterica (serotypes Typhi and Paratyphi A) from blood isolates in Nepal: surveillance of resistance and a search for newer alternatives.
    Pokharel BM; Koirala J; Dahal RK; Mishra SK; Khadga PK; Tuladhar NR
    Int J Infect Dis; 2006 Nov; 10(6):434-8. PubMed ID: 16978898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renaissance of Conventional First-Line Antibiotics in
    Khanal PR; Satyal D; Bhetwal A; Maharjan A; Shakya S; Tandukar S; Parajuli NP
    Biomed Res Int; 2017; 2017():2868143. PubMed ID: 29018810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of phenotypic and WGS-derived antimicrobial resistance profiles of Salmonella enterica serovars Typhi and Paratyphi.
    Day MR; Doumith M; Do Nascimento V; Nair S; Ashton PM; Jenkins C; Dallman TJ; Stevens FJ; Freedman J; Hopkins KL; Woodford N; De Pinna EM; Godbole G
    J Antimicrob Chemother; 2018 Feb; 73(2):365-372. PubMed ID: 29216342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Salmonella enterica serovars in a tertiary care hospital in southern India.
    Choudhary A; Gopalakrishnan R; Nambi PS; Ramasubramanian V; Ghafur KA; Thirunarayan MA
    Indian J Med Res; 2013 Apr; 137(4):800-2. PubMed ID: 23703350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Characterization of Intermediate Susceptible Typhoidal Salmonella to Ciprofloxacin, and its Impact.
    Veeraraghavan B; Anandan S; Muthuirulandi Sethuvel DP; Puratchiveeran N; Walia K; Devanga Ragupathi NK
    Mol Diagn Ther; 2016 Jun; 20(3):213-9. PubMed ID: 26951258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current fluoroquinolone susceptibility criteria for Salmonella needs re-evaluation.
    Acharya D; Malla S; Bhatta DR; Adhikari N; Dumre SP
    Kathmandu Univ Med J (KUMJ); 2012; 10(37):24-9. PubMed ID: 22971857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salmonella enterica serovar Paratyphi A: an emerging cause of febrile illness in Nepal.
    Acharya D; Bhatta DR; Malla S; Dumre SP; Adhikari N; Kandel BP
    Nepal Med Coll J; 2011 Jun; 13(2):69-73. PubMed ID: 22364084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of mechanisms involved in reduced susceptibility to ciprofloxacin in Salmonella enterica serotypes Typhi and Paratyphi A isolates from travellers to Southeast Asia.
    Hassing RJ; Menezes GA; van Pelt W; Petit PL; van Genderen PJ; Goessens WH
    Int J Antimicrob Agents; 2011 Mar; 37(3):240-3. PubMed ID: 21227657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.